This is accurate for niche drugs, but the business model for producing generics isn't solely one in which small players exist. Large omnibus generics manufactu

This is accurate for niche drugs, but the business model for producing generics isn't solely one in which small players exist. Large omnibus generics manufacturers almost always have a larger industrial base and better chemical engineers than one-off drug producers. If the drug has a fairly stable high volume demand, they can finance expenditures for approval, then leverage their production and distribution networks to produce substantial margin even if they dramatically slash prices.